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Patrick W. Serruys, MD, PHD,# Yoshinobu Onuma, MD, PHDzA 75-year-old man with arteriosclerosis oblit-erans was admitted to undergo a stagedpercutaneous peripheral intervention for a
subtotal occlusion of a left peroneal artery (pre-
procedure, Figure 1A,a). After guidewire crossing,
orbital atherectomy was performed with the STEALTH
360 Peripheral Orbital Atherectomy System (OAS),
1.25-mm Solid Micro Crown (Cardiovascular Systems,
Inc., St. Paul, Minnesota) (Figure 1F; post-OAS,
Figure 1B,b). The ﬁrst run was performed at 80,000
rpm for 30 s followed by the second run at 140,000
rpm for 25 s. The ﬁnal balloon angioplasty was per-
formed using Armada 14 (Abbott Vascular, Santa
Clara, California), 2.0/120 mm, 10 atm maximum pres-
sure) (post-procedure, Figure 1C,c). Intravascular ul-
trasound (IVUS) (EagleEye, Volcano Corporation,
Cordova, California) was performed before and after
OAS. The cross section of interest is indicated in
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ware (Medis, Leiden, the Netherlands) revealed frag-
mentation of the calciﬁed plaque demonstrated by
the appearance of multiple “radii” of hypo- or low
echogenicity and by reduction of the calciﬁed area
as detected by the software (10.97% to 4.64%)
(pre-OAS, Figure 1E; post-OAS, Figure E0; Table).
Debulking with OAS was reported to increase the
chance of reaching a desirable balloon angioplasty
result with a higher procedure success rate and with
less acute need for bailout stenting (4). This case report
evaluates quantitatively by echogenicity the debulk-
ing effect of OAS on a peripheral calciﬁed stenosis.
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FIGURE 1 IVUS Echogenicity Analysis Pre- and Post-Orbital Atherectomy
Peripheral angiography pre-procedure (A), post-OAS (B), and post-procedure (C). The magniﬁed view of the lesion of interest is indicated in
a, b, and c. Gray-scale IVUS images (D and D0) and echogenicity analyses (E, E0 and Table) correspond to the yellow arrowhead in a and b.
IVUS ¼ intravascular ultrasound; OAS ¼ orbital atherectomy system.
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